2023 was another exciting year in the world of neuroscience & neurology preprints. The top studies ranged from new risks of COVID and how menstrual cycle hormones reshape the brain to new treatments and biomarkers for MS and Alzheimer’s. Here are your Top 10 neuro preprints for 2023:
- COVID spike protein seeds amyloid-beta fibrils
- Xylazine activates opioid receptors, responds to naloxone
- FOS reports synchronized neuronal input, not neuronal firing
- Bryostatin-1 downregulates inflammatory microglial states
- Novel drug pairings to promote remyelination
- Staging AD pathology through CSF markers
- Linking gut microbiome to disease progression in MS
- Menstrual cycle hormones drive whole brain and regional structural changes
- PSEN1 affecting neurodegeneration without amyloid?
- A plasma biomarker for measuring tau aggregation
We look forward to sharing all the latest preprints with you in 2024.
